Professor of Surgery, UCLA
General Surgery
Dr. Helena R. Chang, MD
|
|
Give Review
Helena R. Chang is an expert in the field of General Surgery. He went to medical school at Temple University School of Medicine. He has 2 awards "Fellow (FACS)" and "Super Doctor". Helena Chang is a published MD as well. He has 17 publications published. The latest was: Combined phosphoproteomics and bioinformatics strategy in deciphering drug resistant related pathways in triple negative breast cancer. Helena Chang accepts Medicare.
Publications
- Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast Cancer?
- The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR.
- Higher levels of GATA3 predict better survival in women with breast Cancer.
- Differential response of triple-negative breast Cancer to a docetaxel and carboplatin-based neoadjuvant treatment.
- Hydrophobic Proteome Analysis of Triple Negative and Hormone-Receptor-Positive-Her2-Negative Breast Cancer by Mass Spectrometer.
- Heterotopic Breast tissue versus occult metastatic carcinoma in lymph node, a diagnostic dilemma.
- Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast Cancer.
- Hydrophobic Fractionation Enhances Novel Protein Detection by Mass Spectrometry in Triple Negative Breast Cancer.
- Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast Cancer biomarkers.
- Accuracy of clinical evaluation of locally advanced breast Cancer in patients receiving neoadjuvant chemotherapy.
- Decreased expression of annexin A1 is correlated with breast Cancer development and progression as determined by a tissue microarray analysis.
- Histopathologic characteristics predicting HER-2/neu amplification in breast Cancer.
- Loss of annexin A1 expression in human breast Cancer detected by multiple high-throughput analyses.
- Clinicopathologic analysis of sentinel lymph node mapping in early breast Cancer.
- Development and preclinical evaluation of a Bacillus Calmette-Guérin-MUC1-based novel breast Cancer vaccine.
- Combined phosphoproteomics and bioinformatics strategy in deciphering drug resistant related pathways in triple negative breast Cancer.
Schools
Temple University School Of Medicine
Episcopal Hospital
Meml Sloan Kettering Cancer
Procedures Preformed
- Biopsy of Breast
- Breast Reconstruction
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Excision of Breast Tumor
- View All
Conditions Treated
- Adrenal Gland Cancer
- Atelectasis
- Breast Cancer
- Breast Lump
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Assurant Health
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Select Plus HMO
- Select PPO
- Carecentrix Health Plan
- Cigna HMO
- Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Blue & Gold HMO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- Humana
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- POMCO Group
- SelectHealth
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- Fellow (FACS)
- Super Doctor
Education
-
Memorial Sloan-Kettering Cancer Center -
Temple University School of Medicine
Hospital
-
UCSF Medical Center -
Ronald Reagan UCLA Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Margaret Olsen, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tuguo N. Sano, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keri E. Lunsford, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Amir Abu-Khalil, MD |
|
|
Dr. Joseph Dinorcia III, MD
This Doctor is OpenDoctor Recommended.
|